日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer

癌细胞中FLT1的激活促进乳腺癌对PARP抑制剂的耐药性

Yifan Tai,Angela Chow #,Seoyoung Han #,Courtney Coker #,Wanchao Ma #,Yifan Gu,Valeria Estrada Navarro,Manoj Kandpal,Hanina Hibshoosh,Kevin Kalinsky,Katia Manova-Todorova ,Anton Safonov,Elaine M Walsh ,Mark Robson,Larry Norton,Richard Baer,Taha Merghoub,Anup K Biswas ,Swarnali Acharyya

Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer

来自转移性三阴性乳腺癌sacituzumab govitecan III期ASCENT研究的亚组分析

Hurvitz, Sara A; Bardia, Aditya; Punie, Kevin; Kalinsky, Kevin; Carey, Lisa A; Rugo, Hope S; Diéras, Véronique; Phan, See; Delaney, Rosemary; Zhu, Yanni; Tolaney, Sara M

Author Correction: Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer

作者更正:来自转移性三阴性乳腺癌sacituzumab govitecan III期ASCENT研究的亚组分析

Hurvitz, Sara A; Bardia, Aditya; Punie, Kevin; Kalinsky, Kevin; Carey, Lisa A; Rugo, Hope S; Diéras, Véronique; Phan, See; Delaney, Rosemary; Zhu, Yanni; Tolaney, Sara M

Tuning Immune-Cold Tumor by Suppressing USP10/B7-H4 Proteolytic Axis Reinvigorates Therapeutic Efficacy of ADCs

通过抑制 USP10/B7-H4 蛋白水解轴调节免疫冷肿瘤可重振 ADC 的治疗效果

Lidan Zeng, Yueming Zhu, Xin Cui, Junlong Chi, Amad Uddin, Zhuan Zhou, Xinxin Song, Mingji Dai, Massimo Cristofanilli, Kevin Kalinsky, Yong Wan

Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity

TRIM21 对 CD73 的蛋白水解调控协调肿瘤免疫原性

Ziyi Fu, Siqi Chen, Yueming Zhu, Donghong Zhang, Ping Xie, Qiao Jiao, Junlong Chi, Shipeng Xu, Yifan Xue, Xinghua Lu, Xinxin Song, Massimo Cristofanilli, William J Gradishar, Kevin Kalinsky, Yongmei Yin, Bin Zhang, Yong Wan

Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy

连续单细胞基因组学揭示了早期乳腺癌患者在接受内分泌联合 CDK4/6 疗法治疗后,耐药性的趋同亚克隆进化。

Jason I Griffiths #,Jinfeng Chen #,Patrick A Cosgrove,Anne O'Dea,Priyanka Sharma,Cynthia Ma,Meghna Trivedi,Kevin Kalinsky,Kari B Wisinski,Ruth O'Regan,Issam Makhoul,Laura M Spring,Aditya Bardia,Frederick R Adler,Adam L Cohen,Jeffrey T Chang,Qamar J Khan,Andrea H Bild

Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers

抑制自分泌IL-6-JAK2-STAT3-钙卫蛋白轴作为HR-/HER2+乳腺癌的靶向治疗

Ruth Rodriguez-Barrueco ,Jiyang Yu ,Laura P Saucedo-Cuevas ,Mireia Olivan ,David Llobet-Navas ,Preeti Putcha ,Veronica Castro ,Eva M Murga-Penas ,Ana Collazo-Lorduy ,Mireia Castillo-Martin ,Mariano Alvarez ,Carlos Cordon-Cardo ,Kevin Kalinsky ,Matthew Maurer ,Andrea Califano ,Jose M Silva